Clinical and molecular characterization of childhood cancer susceptibility syndromes

Clinical and molecular characterization of childhood cancer susceptibility syndromes - Genetics of childhood cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30743

Enrollment

Registered

2007-06-18

Start date

2007-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood cancer paediatric malignancies

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with childhoodcancer and - a congenital defect and/or - developmental delay and/or - dysmorphisms and/or - a positive family history for cancer (sibs with childhood cancer or a parent with cancer at an age younger than 50 years)

Exclusion criteria

Exclusion criteria: Cancer predisposition syndromes with a known molecular cause, for example Bechwith Wiedemann syndrome

Design outcomes

Primary

Measure	Time frame
Putative novel childhood malignancy predisposing genes.	—

Secondary

Measure	Time frame
Knowledge, experience and guidelines for the recognition and counseling of the hereditary character of childhood malignancy.	—

Countries

Netherlands

Outcome results